User profiles for Alessandro Vito Lasorsa
 | Vito Alessandro LasorsaCEINGE - Biotecnologie Avanzate Scarl. Università degli studi di Napoli "Federico II" Verified email at ceinge.unina.it Cited by 773 |
19p loss is significantly enriched in older age neuroblastoma patients and correlates with poor prognosis
VA Lasorsa, F Cimmino, M Ognibene… - NPJ genomic …, 2020 - nature.com
Genomic aberrations of neuroblastoma occurring in late childhood and adolescence are
still understudied. Publicly available DNA copy number profiles of 556 tumors (discovery set) …
still understudied. Publicly available DNA copy number profiles of 556 tumors (discovery set) …
[HTML][HTML] Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression
VA Lasorsa, D Formicola, P Pignataro, F Cimmino… - Oncotarget, 2016 - ncbi.nlm.nih.gov
… Vito Alessandro Lasorsa, 1, 2 Daniela Formicola, 1, 2 Piero Pignataro, 1, 2 Flora Cimmino,
1, 2 Francesco Maria Calabrese, 3 Jaume Mora, 4 Maria Rosaria Esposito, 5 Marcella …
1, 2 Francesco Maria Calabrese, 3 Jaume Mora, 4 Maria Rosaria Esposito, 5 Marcella …
[HTML][HTML] Genetic analysis of the coronavirus SARS-CoV-2 host protease TMPRSS2 in different populations
In December 2019, a new infectious respiratory disease emerged in Wuhan, Hubei province,
China (Huang et al., 2020; Wang et al., 2020; Zhu et al., 2020). It diffused rapidly worldwide …
China (Huang et al., 2020; Wang et al., 2020; Zhu et al., 2020). It diffused rapidly worldwide …
HIF-1 transcription activity: HIF1A driven response in normoxia and in hypoxia
F Cimmino, M Avitabile, VA Lasorsa, A Montella… - BMC medical …, 2019 - Springer
Background HIF1A (Hypoxia-Inducible-Factor 1A) expression in solid tumors is relevant to
establish resistance to therapeutic approaches. The use of compounds direct against hypoxia …
establish resistance to therapeutic approaches. The use of compounds direct against hypoxia …
[PDF][PDF] Common variants at 21q22. 3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe COVID-19
The established risk factors of coronavirus disease 2019 (COVID-19) are advanced age,
male sex, and comorbidities, but they do not fully explain the wide spectrum of disease …
male sex, and comorbidities, but they do not fully explain the wide spectrum of disease …
A new butyrate releaser exerts a protective action against SARS-CoV-2 infection in human intestine
…, M Capasso, E Punzo, V Ferrucci, VA Lasorsa… - Molecules, 2022 - mdpi.com
Butyrate is a major gut microbiome metabolite that regulates several defense mechanisms
against infectious diseases. Alterations in the gut microbiome, leading to reduced butyrate …
against infectious diseases. Alterations in the gut microbiome, leading to reduced butyrate …
Regulatory Noncoding and Predicted Pathogenic Coding Variants of CCR5 Predispose to Severe COVID-19
Genome-wide association studies (GWAS) found locus 3p21.31 associated with severe
COVID-19. CCR5 resides at the same locus and, given its known biological role in other …
COVID-19. CCR5 resides at the same locus and, given its known biological role in other …
Inherited rare variants in homologous recombination and neurodevelopmental genes are associated with increased risk of neuroblastoma
Background Neuroblastoma (NB) is the most common solid extracranial paediatric tumour.
Genome-wide association studies have driven the discovery of common risk variants, but no …
Genome-wide association studies have driven the discovery of common risk variants, but no …
miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinase
…, AE De Stefano, PLC Iervolino, VA Lasorsa… - British journal of …, 2020 - nature.com
Background Aberrant expression of microRNAs (miR) has been proposed as non-invasive
biomarkers for breast cancers. The aim of this study was to analyse the miR-622 level in the …
biomarkers for breast cancers. The aim of this study was to analyse the miR-622 level in the …
[HTML][HTML] A targeted gene panel for circulating tumor DNA sequencing in neuroblastoma
F Cimmino, VA Lasorsa, S Vetrella, A Iolascon… - Frontiers in …, 2020 - frontiersin.org
Background Liquid biopsies do not reflect the complete mutation profile of the tumor but have
the potential to identify actionable mutations when tumor biopsies are not available as well …
the potential to identify actionable mutations when tumor biopsies are not available as well …
